GE HealthCare Technologies (GEHC) Gross Margin (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Gross Margin came in at 41.17% in Q2 2026, up 153.0% YoY from 16.27% in Q2 2025, and up 6.85% on a QoQ basis from 38.53% in Q1 2026.
GE HealthCare Technologies (GEHC) Gross Margin (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Gross Margin data on file, last reported at 41.17% in Q2 2026.
- Quarterly Gross Margin rose 153.0% year-over-year to 41.17% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 39.54% (down 203.0% YoY) and the FY2025 annual result came in at 39.99%, down 172.0% from the prior year.
- Gross Margin rose to 41.17% in Q2 2026, from 38.53% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 42.77% in Q4 2024 to a low of 38.53% in Q1 2026.
- A 5-year average of 40.28% and a median of 40.15% in 2023 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin jumped 229 bps — and 2026, when it plunged 359 bps.
- Tracing GEHC's Gross Margin over 5 years: stood at 39.13% in 2022, then increased by 6 bps to 41.41% in 2023, then advanced by 3 bps to 42.77% in 2024, then declined by 7 bps to 39.68% in 2025, then grew by 4 bps to 41.17% in 2026.
- The last three Gross Margin figures came in at 41.17% (Q2 2026), 38.53% (Q1 2026), and 39.68% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.82 Bn | 196.22 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 126.80 Bn | 123.33 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 118.88 Bn | 109.66 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 74.25 Bn | 73.71 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 51.59 Bn | 47.34 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.99 Bn | 33.04 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.23 Bn | 22.91 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 45.84% |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn | 70.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.17% |
| Mar 31, 2026 | 38.53% |
| Dec 31, 2025 | 39.68% |
| Sep 30, 2025 | 38.69% |
| Jun 30, 2025 | 39.64% |
| Mar 31, 2025 | 42.12% |
| Dec 31, 2024 | 42.77% |
| Sep 30, 2024 | 41.66% |
| Jun 30, 2024 | 41.37% |
| Mar 31, 2024 | 40.90% |
| Dec 31, 2023 | 41.41% |
| Sep 30, 2023 | 40.13% |
| Jun 30, 2023 | 40.27% |
| Mar 31, 2023 | 40.17% |
| Dec 31, 2022 | 39.13% |
| Sep 30, 2022 | 38.75% |
| Jun 30, 2022 | 40.05% |
| Mar 31, 2022 | 38.64% |